Coldstream Capital Management’s Chemours CC Stock Holding History

Coldstream Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,110	Closed	-$55.6K	–	1490
2025 Q1	$55.6K	Buy	+4,110	New	+$68.3K	﹤0.01%	1656

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Coldstream Capital Management's CC Position: Q2 2025 in Review

Coldstream Capital Management sold out of Chemours (CC) in Q2 2025, closing a stake of 4,110 shares — an estimated $55.6K sold.

Coldstream Capital Management first reported a position in CC in Q1 2025 and held it in 1 quarter. The position peaked at $55.6K in Q1 2025. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

Coldstream Capital Management reported no remaining Chemours position as of Q2 2025 after selling out during the quarter.
Coldstream Capital Management sold 4,110 Chemours shares in Q2 2025, an estimated $55.6K.
Coldstream Capital Management first reported a position in Chemours in Q1 2025 and held it in 1 quarter.
Coldstream Capital Management's Chemours position peaked at $55.6K in Q1 2025.
434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.